RI
WHWK

RTW Investments’s Whitehawk Therapeutics WHWK Stock Holding History

RTW Investments’s Portfolio WHWK Stock Details WHWK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-764,701
Closed -$9.81M – 75
2022
Q4 		$9.81M Hold
764,701
– – 0.2% 48
2022
Q3 		$10.8M Hold
764,701
– – 0.25% 52
2022
Q2 		$9.42M Hold
764,701
– – 0.24% 63
2022
Q1 		$13M Hold
764,701
– – 0.27% 62
2021
Q4 		$18.5M Hold
764,701
– – 0.27% 73
2021
Q3 		$21.3M Buy
+764,701
New +$23.3M 0.32% 60

Other funds holding WHWK

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
AIM
Alerce Investment Management Chicago, Illinois $56.8M AUM 31.17% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
DCMIC
Decheng Capital Management III (Cayman) Grand Cayman, Cayman Islands $300M AUM 15.74% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

RTW Investments's WHWK Position: Q1 2023 in Review

RTW Investments sold out of Whitehawk Therapeutics (WHWK) in Q1 2023, closing a stake of 764,701 shares — an estimated $9.81M sold.

RTW Investments first reported a position in WHWK in Q3 2021 and held it in 6 quarters. The position peaked at $21.3M in Q3 2021. 70 funds tracked by Wall St. Rank hold WHWK as of Q1 2023.

  • RTW Investments reported no remaining Whitehawk Therapeutics position as of Q1 2023 after selling out during the quarter.
  • RTW Investments sold 764,701 Whitehawk Therapeutics shares in Q1 2023, an estimated $9.81M.
  • RTW Investments first reported a position in Whitehawk Therapeutics in Q3 2021 and held it in 6 quarters.
  • RTW Investments's Whitehawk Therapeutics position peaked at $21.3M in Q3 2021.
  • 70 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q1 2023.

Based on RTW Investments's 13F filing for Q1 2023, filed 15 May 2023.